|Industry||Health & Pharmaceutical Products|
|Agency||DraftFCB New York|
|Creative Director||Mike Devlin|
|Art Director||Dan Krippahne|
|Producer||Jason Wolk, Beth Fitzpatrick|
Credits & Description
The campaign, created by Draftfcb Healthcare, is inspired by an outpouring of stories about the positive impact Gilenya has had on the lives of its users. Gilenya is the first oral disease modifying therapy for people living with relapsing forms of Multiple Sclerosis (MS). Prior to this revolutionary pill, the only treatment options patients had required regular injections or infusions. Not only does Gilenya reduce the frequency of relapse by 52%, but the pill integrates better into the busy lives of those who are effected. It also provides a platform for patients to take a stance against the disease.